Effects of a Novel Dual Phosphodiesterase 3 and 4 Inhibitor TQC3721 in Patients with COPD in China (PACER-II): a phase 2, multicentre, randomised, double-blind, placebo-controlled trial

已完结 10 由 wlm 发布于 2026/4/23 11:40:43

DOI:10.1016/j.chest.2025.12.055
作者：Li-Xiu He, Ling Yang, Zu-Ke Xiao, Rong Qiu, Fa-Ming Yu, Li-Qin Wu, Wei-Hua Zhang, Xun-Chao Liu, Ling-Feng Min, Xiu-Qin Ma, Jian-Zhong Jiang, Bo Yuan, Ran-Ran Dai, Dong Liu, Xiao-Hua Li, Tao Wang, Jie
文献类型：期刊论文
补充材料：只需要正文

Elsevier

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Polyanion hydrogel electrolyte with a high Zn2? transference number for dendrite-free aqueous zinc-ion batteries J. Mater. Chem. A, 2025, 13, 16182–16192